We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$330M
2
CTRA
Coterra Energy
CTRA
+$214M
3
BSX icon
Boston Scientific
BSX
+$204M
4
RBA icon
RB Global
RBA
+$183M
5
CVX icon
Chevron
CVX
+$131M

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SM icon
701
SM Energy
SM
$7.96B
$9.35M 0.01%
+300,000
New +$6.84M
ORKA
702
Oruka Therapeutics
ORKA
$5.56B
$9.32M 0.01%
+190,030
New +$6.6M
PNR icon
703
Pentair
PNR
$10.2B
$9.23M 0.01%
106,002
-91,700
-46% -$8.99M
EXR icon
704
Extra Space Storage
EXR
$31.2B
$9.19M 0.01%
70,100
-166,500
-70% -$23.5M
SJM icon
705
J.M. Smucker
SJM
$12.6B
$9.18M 0.01%
95,227
-1,100
-1% -$115K
ZBRA icon
706
Zebra Technologies
ZBRA
$12.4B
$9.18M 0.01%
43,911
-135,092
-75% -$31.7M
SOLV icon
707
Solventum
SOLV
$13.5B
$9.14M 0.01%
+140,022
New +$10.4M
TMP icon
708
Tompkins Financial
TMP
$1.45B
$8.95M 0.01%
113,570
+53,570
+89% +$4.17M
TTD icon
709
Trade Desk
TTD
$8.13B
$8.91M 0.01%
392,800
-4,700
-1% -$136K
SMCI icon
710
Super Micro Computer
SMCI
$19.5B
$8.86M 0.01%
388,900
-13,800
-3% -$414K
GKOS icon
711
Glaukos
GKOS
$9.02B
$8.81M 0.01%
81,878
-168,122
-67% -$18.9M
JBHT icon
712
JB Hunt Transport Services
JBHT
$27.1B
$8.77M 0.01%
41,407
+25,800
+165% +$5.5M
BIOA
713
BioAge Labs
BIOA
$968M
$8.74M 0.01%
500,000
-550,000
-52% -$10.6M
MTD icon
714
Mettler-Toledo International
MTD
$26.8B
$8.73M 0.01%
6,924
+666
+11% +$898K
VEL icon
715
Velocity Financial
VEL
$683M
$8.73M 0.01%
482,715
+32,669
+7% +$617K
ANRO icon
716
Alto Neuroscience
ANRO
$1.04B
$8.65M 0.01%
+385,000
New +$7.14M
IVZ icon
717
Invesco
IVZ
$13.3B
$8.65M 0.01%
356,169
-5,700
-2% -$149K
CAMP icon
718
CAMP4 Therapeutics
CAMP
$164M
$8.65M 0.01%
1,960,784
-220,895
-10% -$1.05M
TENX icon
719
Tenax Therapeutics
TENX
$385M
$8.64M 0.01%
540,126
+456,793
+548% +$6.18M
ARQT icon
720
Arcutis Biotherapeutics
ARQT
$3.42B
$8.62M 0.01%
+366,000
New +$9.34M
CDW icon
721
CDW
CDW
$17.1B
$8.62M 0.01%
71,200
-6,300
-8% -$796K
IPSC icon
722
Century Therapeutics
IPSC
$381M
$8.56M 0.01%
3,789,538
+1,950,838
+106% +$4.1M
NERV icon
723
Minerva Neurosciences
NERV
$188M
$8.55M 0.01%
1,419,000
-1,419,000
-50% -$8.14M
FLOC
724
Flowco Holdings
FLOC
$843M
$8.24M 0.01%
400,000
+290,000
+264% +$6.29M
HQY icon
725
HealthEquity
HQY
$7.91B
$8.11M 0.01%
+97,000
New +$7.96M
27 28
29
30 31

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.